Bioceltix S.A.
Develops stem cell-based medicinal products for veterinary use.
BCX | WAR
Overview
Corporate Details
- ISIN(s):
- PLBCLTX00019 (+1 more)
- LEI:
- 259400QZD5JYK8SLZU51
- Country:
- Poland
- Address:
- Wrocław Bierutowska 57-59/BUD.III, 51-317 Wrocław
- Website:
- https://bioceltix.com/en/
- Sector:
- Manufacturing
Description
Bioceltix S.A. is a biopharmaceutical company that develops stem cell-based medicinal products for veterinary use. The company focuses on creating therapies that utilize Mesenchymal Stem Cells (MSCs) as the active pharmaceutical ingredient. Its product pipeline is aimed at treating immunological and inflammatory conditions in companion animals, including dogs, cats, and horses. A key area of development includes treatments for conditions such as atopic dermatitis in dogs and degenerative joint disease.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-07 18:29 |
Informacja o liczbie akcji i głosów
|
Polish | 74.3 KB | ||
| 2024-05-07 18:29 |
Klauzula informacyjna o przetwarzaniu danych osobowych
|
Polish | 174.2 KB | ||
| 2024-05-07 18:29 |
Formularz głosowania przez pełnomocnika
|
Polish | 160.9 KB | ||
| 2024-05-07 18:29 |
Formularze pełnomocnictwa
|
Polish | 115.1 KB | ||
| 2024-05-07 18:29 |
Zestawienie zmian statutu
|
Polish | 86.8 KB | ||
| 2024-05-07 18:29 |
Opinia Zarządu
|
Polish | 73.1 KB | ||
| 2024-05-07 18:29 |
Projekty uchwał wraz z uzasadnieniem
|
Polish | 148.9 KB | ||
| 2024-05-07 18:29 |
Ogłoszenie o zwołaniu NWZ
|
Polish | 145.2 KB | ||
| 2024-05-07 18:29 |
Zwołanie NWZ na dzień 3 czerwca 2024 roku - Content (PL)
|
Polish | 2.1 KB | ||
| 2024-05-07 17:38 |
Przyjęcie planu budowy wielkoskalowej wytwórni komórek macierzystych i sposobu …
|
Polish | 5.4 KB | ||
| 2024-04-26 17:12 |
Podpisy do opinii biegłego rewidenta z badania Sprawozdania Finansowego Biocelt…
|
Polish | 10.3 KB | ||
| 2024-04-26 17:12 |
Opinia biegłego rewidenta z badania Sprawozdania Finansowego Bioceltix S.A. za …
|
Polish | 2.9 MB | ||
| 2024-04-26 17:12 |
Podpisy do Raportu okresowego rocznego Bioceltix S.A. za rok 2023
|
Polish | 20.9 KB | ||
| 2024-04-26 17:12 |
Raport okresowy roczny Bioceltix S.A. za rok 2023
|
Polish | 17.3 MB | ||
| 2024-04-26 17:12 |
Podpisy do Sprawozdania z Działalności Bioceltix S.A. za okres sprawozdawczy za…
|
Polish | 20.9 KB |
Automate Your Workflow. Get a real-time feed of all Bioceltix S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Bioceltix S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Bioceltix S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
